Cellectis (CLLS) Research & Development: 2015-2023
Historic Research & Development for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$19.1 million.
- Cellectis' Research & Development rose 19.98% to -$19.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$84.1 million, marking a year-over-year increase of 20.34%. This contributed to the annual value of -$97.5 million for FY2022, which is 17.26% up from last year.
- Cellectis' Research & Development amounted to -$19.1 million in Q3 2023, which was up 14.08% from -$22.2 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Research & Development ranged from a high of -$14.5 million in Q1 2019 and a low of -$34.3 million during Q3 2021.
- Moreover, its 3-year median value for Research & Development was -$25.6 million (2022), whereas its average is -$26.0 million.
- In the last 5 years, Cellectis' Research & Development crashed by 78,769.26% in 2019 and then soared by 30.55% in 2022.
- Quarterly analysis of 5 years shows Cellectis' Research & Development stood at -$30.3 million in 2019, then grew by 22.85% to -$23.4 million in 2020, then decreased by 26.24% to -$29.5 million in 2021, then increased by 27.43% to -$21.4 million in 2022, then grew by 19.98% to -$19.1 million in 2023.
- Its last three reported values are -$19.1 million in Q3 2023, -$22.2 million for Q2 2023, and -$21.4 million during Q1 2023.